The timeline for visible skin improvements, when they occur, typically extends over 8-16 weeks of consistent injectable glutathione therapy
The candidate agents extend current antibiotics classes with, for example, second-generation polymyxins (MRX-8 and upleganan, both in Phase I), an aminoglycoside (apramycin, Phase I), a tetracycline (zifanocycline, Phase I) and a macrolide (nafithromycin, Phase II) as well as new beta-lactam/beta-lactamase inhibitor (BL/BLI) combinations (ceftibuten/ledaborbactam, Phase I
Warning Signs Do you suffer from any of the following: Always tired Lack of energy Aches and pains - joints or muscles hurting Foggy brain Low Immunity Poor sleep If you answered "yes" to one or more, you might have a glutathione deficiency
Zhang X, Tu D, Li S et al (2022) A novel synthetic peptide SVHRSP attenuates dopaminergic neurodegeneration by inhibiting NADPH oxidase-mediated neuroinflammation in experimental models of Parkinsons disease
